Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary ...

Chemomab's OLE study of nebokitug in PSC patients confirmed safety and showed improvements in liver stiffness, fibrosis ...

Mirum Pharmaceuticals, Inc. today announced that its partner, Takeda Pharmaceutical Company Limited, has received approval by the Japanese Ministry of Health, Labour, and Welfare for LIVMARLI® ...

Treatment of this autoimmune liver disease should also address various symptoms and complications arising from any associated autoimmune diseases, particularly cholestasis and cirrhosis-related ...

Fat-soluble vitamins (FSV) are also malabsorbed in cholestasis, and regular supplementation ... an ideal feed for infants with liver disease would be a palatable (whole protein) formula with ...

Chemomab Therapeutics (CMMB) announced results from the Open Label Extension portion of the Phase 2 SPRING trial assessing nebokitug as a ...

Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This ...

Liver disease is seriously endangering human health in the world ... The study by Han et al. discussed about the anti-cholestatic mechanism of zhuyu pill on rat model, which was induced by naphthyl ...

Damaged human livers can repair themselves. Even livers badly scarred from excessive alcohol use, including alcohol-related ...

The liver is a vital organ, crucial to digestion, metabolism and the elimination of toxins. It has a unique ability, ...

In 2021, liver disease led to 2.7 million emergency department (ED) visits in the U.S., 2 million hospitalizations, and ...